| Troy Health & Rehabilitation Center | |
| 515 Elba Highway, Troy, Alabama 36079 | |
| (334) 566-0880 | |
| Name | Troy Health & Rehabilitation Center |
|---|---|
| Location | 515 Elba Highway, Troy, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 220 |
| Occupancy Rate | 53.45% |
| Medicare ID (CCN) | 015213 |
| Legal Business Name | Caring Corporation Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1528203924 |
| Organization Name | TROY HEALTH & REHAB |
| Address | 515 Elba Hwy, Troy, AL 36079 |
| Phone Number | 334-566-0880 |
News Archive
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, today announced it has opened a new fund to provide financial assistance to Medicare patients suffering from renal cell carcinoma (RCC).
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), led by Dr. Alicia G. Arroyo, have identified a function of a protease that could be targeted for the treatment of some infections and even tumor metastasis.
New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease.
Magnetic iron oxide nanoparticles have already proven their utility for imaging metastatic breast cancer lesions in sentinel lymph nodes, and numerous groups are attempting to use iron nanoparticles in other imaging applications.
› Verified 3 days ago
| NPI Number | 1922087212 |
| Organization Name | CARING CORPORATION INC |
| Doing Business As | TROY HEALTH AND REHABILITATION CENTER |
| Address | 515 Elba Highway, Troy, AL 36079 |
| Phone Number | 334-566-0880 |
News Archive
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, today announced it has opened a new fund to provide financial assistance to Medicare patients suffering from renal cell carcinoma (RCC).
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), led by Dr. Alicia G. Arroyo, have identified a function of a protease that could be targeted for the treatment of some infections and even tumor metastasis.
New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease.
Magnetic iron oxide nanoparticles have already proven their utility for imaging metastatic breast cancer lesions in sentinel lymph nodes, and numerous groups are attempting to use iron nanoparticles in other imaging applications.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, today announced it has opened a new fund to provide financial assistance to Medicare patients suffering from renal cell carcinoma (RCC).
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), led by Dr. Alicia G. Arroyo, have identified a function of a protease that could be targeted for the treatment of some infections and even tumor metastasis.
New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease.
Magnetic iron oxide nanoparticles have already proven their utility for imaging metastatic breast cancer lesions in sentinel lymph nodes, and numerous groups are attempting to use iron nanoparticles in other imaging applications.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.51 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.63 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.85 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.7 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.3 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.91 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 22.6 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.24 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33.13 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.42 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 85.42 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 71.97 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 21.5 | 82.93 |
News Archive
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, today announced it has opened a new fund to provide financial assistance to Medicare patients suffering from renal cell carcinoma (RCC).
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), led by Dr. Alicia G. Arroyo, have identified a function of a protease that could be targeted for the treatment of some infections and even tumor metastasis.
New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease.
Magnetic iron oxide nanoparticles have already proven their utility for imaging metastatic breast cancer lesions in sentinel lymph nodes, and numerous groups are attempting to use iron nanoparticles in other imaging applications.
› Verified 3 days ago
Troy Health & Rehabilitation Center Location: 515 Elba Highway, Troy, Alabama 36079 Phone: (334) 566-0880 |